(Q22252937)

PubMed

PubMed publication ID

7 February 2023

2

Kassandra L. Munger

Kassandra L

Munger

1 reference

PubMed

PubMed publication ID

17444504

Epstein-Barr virus infection

7 February 2023

language of work or name

English

0 references

publication date

April 2007

0 references

published in

Annals of Neurology

0 references

volume

61

0 references

issue

4

0 references

page(s)

288-299

0 references

cites work

1 reference

7 January 2021

Risk of Multiple Sclerosis Related to Age at Immigration to Israel

1 reference

7 January 2021

Epstein-Barr Virus Antibodies in Multiple Sclerosis

1 reference

7 January 2021

Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis

1 reference

7 January 2021

Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis

1 reference

7 January 2021

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

1 reference

7 January 2021

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

1 reference

7 January 2021

Epstein-Barr virus in pediatric multiple sclerosis

1 reference

7 January 2021

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

1 reference

7 January 2021

Exposure to infant siblings during early life and risk of multiple sclerosis

1 reference

7 January 2021

Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure

1 reference

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

7 January 2021

Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography

1 reference

7 January 2021

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

1 reference

7 January 2021

Antibody responses to measles virus and canine distemper virus in multiple sclerosis

1 reference

7 January 2021

Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis

1 reference

7 January 2021

HHV-6 A- or B-specific P41 antigens do not reveal virus variant-specific IgG or IgM responses in human serum

1 reference

7 January 2021

Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response

1 reference

7 January 2021

Genetic analysis of multiple sclerosis

1 reference

7 January 2021

A note on the absence of ‘clustering’ of multiple sclerosis cases

1 reference

7 January 2021

Clustering during childhood of multiple sclerosis patients

1 reference

7 January 2021

Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests

1 reference

7 January 2021

Migrant studies in multiple sclerosis

1 reference

7 January 2021

1 reference

7 January 2021

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

1 reference

7 January 2021

Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis

1 reference

7 January 2021

Role of viruses in etiology and pathogenesis of multiple sclerosis

1 reference

7 January 2021

Multiple sclerosis: occupation and social group at onset.

1 reference

7 January 2021

Eskimos and multiple sclerosis

1 reference

7 January 2021

Multiple sclerosis and Epstein-Barr virus

1 reference

7 January 2021

Multiple sclerosis in the Faroe Islands: an epitome

1 reference

7 January 2021

Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients

1 reference

7 January 2021

Infectious causes of multiple sclerosis

1 reference

7 January 2021

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

1 reference

7 January 2021

Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk.

1 reference

7 January 2021

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

1 reference

7 January 2021

T-cell control of Epstein–Barr virus-infected B cells is lost during P. falciparum malaria

1 reference

7 January 2021

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

1 reference

7 January 2021

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

1 reference

7 January 2021

No one is naive: the significance of heterologous T-cell immunity.

1 reference

7 January 2021

Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis

1 reference

7 January 2021

A role of late Epstein-Barr virus infection in multiple sclerosis

1 reference

7 January 2021

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis

1 reference

7 January 2021

Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.

1 reference

7 January 2021

The effect of infections on susceptibility to autoimmune and allergic diseases

1 reference

7 January 2021

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

1 reference

7 January 2021

Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells

1 reference

7 January 2021

An Epstein-Barr virus-associated superantigen

1 reference

7 January 2021

Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis

1 reference

7 January 2021

Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease

1 reference

7 January 2021

High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection.

1 reference

7 January 2021

Human herpesvirus 6 variant A, but not variant B, infects EBV-positive B lymphoid cells, activating the latent EBV genome through a BZLF-1-dependent mechanism

1 reference

7 January 2021

Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis

1 reference

7 January 2021

Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease

1 reference

7 January 2021

Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population

1 reference

7 January 2021

The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia

1 reference

7 January 2021

Viral antibody in the cerebrospinal fluid and serum of multiple sclerosis patients.

1 reference

7 January 2021

Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter.

1 reference

7 January 2021

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

1 reference

7 January 2021

Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis

1 reference

7 January 2021

Incidence of Infectious Mononucleosis at the Universities of California and Hawaii

1 reference

7 January 2021

Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis

1 reference

7 January 2021

Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway

1 reference

7 January 2021

Infectious mononucleosis in a general population

1 reference

7 January 2021

Infectious mononucleosis: epidemiologic patterns at United States colleges and universities

1 reference

7 January 2021

Epstein-Barr virus and multiple sclerosis

1 reference

7 January 2021

A positive correlation between the precursor frequency of cytotoxic lymphocytes to autologous Epstein-Barr virus-transformed B cells and antibody titer level against Epstein-Barr virus-associated nuclear antigen in healthy seropositive individuals

1 reference

7 January 2021

Measles antibodies detected with various techniques in sera of patients with multiple sclerosis

1 reference

7 January 2021

Multiple sclerosis in the Faroe Islands. III. An alternative assessment of the three epidemics

1 reference

7 January 2021

Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948-64 based on the Danish Multiple Sclerosis Registry

1 reference

7 January 2021

MS epidemiology world wide. One view of current status

1 reference

7 January 2021

The implications of Epstein-Barr virus in multiple sclerosis--a review

1 reference

7 January 2021

A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters

1 reference

7 January 2021

Seroprevalence of herpes simplex virus type 2 in multiple sclerosis

1 reference

7 January 2021

Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study.

1 reference

7 January 2021

1 reference

7 January 2021

Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

1 reference

7 January 2021

Epidemiologic evidence for multiple sclerosis as an infection

1 reference

7 January 2021

Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers

1 reference

7 January 2021

Multiple sclerosis among immigrants in Greater London

1 reference

7 January 2021

Multiple sclerosis among immigrants

1 reference

7 January 2021

Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa

1 reference

7 January 2021

Multiple sclerosis after infectious mononucleosis: record linkage study

1 reference

7 January 2021

Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections

1 reference

7 January 2021

Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation

1 reference

7 January 2021

Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies

1 reference

7 January 2021

Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies

1 reference

7 January 2021

Motor neuron disease and multiple sclerosis among immigrants to England from the Indian subcontinent, the Caribbean, and east and west Africa

1 reference

7 January 2021

Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation

1 reference

7 January 2021

Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway

1 reference

7 January 2021

The enigmatic epidemiology of nasopharyngeal carcinoma

1 reference

7 January 2021

Was there an epidemic of multiple sclerosis in the Faroe Islands?

1 reference

7 January 2021

Analysis of the 'epidemic' of multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological aspects

1 reference

7 January 2021

Analysis of the 'epidemic' of multiple sclerosis in the Faroe Islands. II. Biostatistical aspects

1 reference

7 January 2021

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

1 reference

7 January 2021

The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis

1 reference

7 January 2021

Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results

1 reference

7 January 2021

Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis

1 reference

7 January 2021

Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000.

1 reference

7 January 2021

A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts

1 reference

7 January 2021

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

1 reference

7 January 2021

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

1 reference

7 January 2021

Studies on the natural history of multiple sclerosis: 3. Epidemiologic analysis of the Army experience in World War II

1 reference

7 January 2021

Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands

1 reference

7 January 2021

Migration and risk of multiple sclerosis

1 reference

7 January 2021

Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution

1 reference

7 January 2021

The etiology of multiple sclerosis: temporal-spatial clustering indicating two environmental exposures before onset

1 reference

7 January 2021

Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis

1 reference

7 January 2021

Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS.

1 reference

7 January 2021

Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS.

1 reference

7 January 2021

Selected reviews common childhood and adolescent infections and multiple sclerosis.

1 reference

7 January 2021

Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS.

1 reference

7 January 2021

Geographic variation of MS incidence in two prospective studies of US women

1 reference

7 January 2021

Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.

1 reference

7 January 2021

Ubiquitous pathogens: links between infection and autoimmunity in MS?

1 reference

7 January 2021

Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

1 reference

7 January 2021

Infectious mononucleosis in Greenland: a disease of the non-indigenous population.

1 reference

7 January 2021

Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction.

1 reference

7 January 2021